Ying‐Hsu Chang

Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2

Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai et al. · Science Translational Medicine · 2017 · 206 citations

The role of PD-L1 in the radiation response and clinical outcome for bladder cancer

Chun‐Te Wu, Wen‐Cheng Chen, Ying‐Hsu Chang et al. · Scientific Reports · 2016 · 183 citations · Full text

Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer

Mu‐Yi Hua, Hung‐Wei Yang, Cheng‐Keng Chuang et al. · Biomaterials · 2010 · 128 citations

Nanoparticles, Nanomedicine, Engineering +5

Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy

Mu‐Yi Hua, Hung‐Wei Yang, Hao-Li Liu et al. · Biomaterials · 2011 · 85 citations

Nanoparticles, Nanomedicine, Magnetism +13

Identifying cancer origin using circulating tumor cells

Si-Hong Lu, Wen‐Sy Tsai, Ying‐Hsu Chang · Cancer Biology & Therapy · 2016 · 72 citations · Full text

Immunology, Immunoediting, Pathology +16